Syndax Pharmaceuticals Inc
SNDX
$11.45+0.29 (+2.60%)
Jun 7, 2025, 4:00 PM
Financials
| 52Week High | 25.07 | 52Week Low | 8.58 |
| Beta | 0.78 | Current Ratio Annual | 5.82 |
| Current Ratio Quarterly | 5.80 | Market Cap | 985.24M |
| Net Profit Margin TTM | -757.52 | Operating Margin TTM | -786.59 |
| Price To Book | 4.58 | Price To Sales TTM | 22.53 |
| Quick Ratio Annual | 5.77 | Quick Ratio Quarterly | 5.69 |
| Return On Assets TTM | -58.41 | Return On Equity TTM | -101.60 |
| Return On Investment TTM | -66.48 | Revenue Growth3Y | -44.66 |
| Revenue Growth5Y | 73.64 | Revenue Per Share TTM | 0.51 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 220 | 2 | 2 | 2 | 3 | 0 | 99.97M | $1.28B |
| Mar 31, 2025 | 222 | 31 | 28 | 86 | 63 | 36 | 102.94M | $1.24B |
| Change | 2(1%) | 29(1450%) | 26(1300%) | 84(4200%) | 60(2000%) | 36 | 2.97M(3%) | $42.38M(3%) |